GlaxoSmithKline

RSS Subscribe

GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.

GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer.

Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.

GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products.

The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders.

Based on 2001 Annual Results, GSK had sales of £20.5 billion ($29.5 billion) and profit before tax of £6.2 billion ($8.8 billion). Pharmaceutical sales accounted for £17.2 billion ($24.8 billion) with new products representing 22% of total pharmaceutical sales.

GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Over 42,000 employees work at 99 manufacturing sites in 39 countries and over 16,000 are in R&D.

GSK R&D is based at 24 sites in seven countries. The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about £2.4bn/$4bn.

The GlaxoSmithKline Web site is not intended to give investment advice, promote the use of GlaxoSmithKline products or provide information on which to base medical treatment. If you have questions regarding any GlaxoSmithKline products, please consult your health care provider. We cannot answer product-related questions through this Web site.

You can contact GlaxoSmithKline on the following numbers:

In the UK: +44 (0) 20 8047 5000
In the US: +1 888 825 5249

Web: www.gsk.com

Articles by GlaxoSmithKline

Drug Discovery & Development

  • Six Researchers Share $500,000 Award For Work on HIV/AIDS Treatment Breakthroughs »

    GlaxoSmithKline Press Office
    Six HIV and AIDS researchers will split $500,000 as this year's recipients of the GlaxoSmithKline (GSK) Drug Discovery and Development Award. The unrestricted research award program is funded by GSK to support independent, innovative and novel research in the development of HIV/AIDS therapeutics.

RSS